1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/52884
Full metadata record
DC FieldValueLanguage
dc.creatorEduardo Paulinopt_BR
dc.creatorAndréia Cristina de Melopt_BR
dc.creatorAgnaldo Lopes da Silva Filhopt_BR
dc.creatorLuiza de Freitas Macielpt_BR
dc.creatorLuiz Claudio Santos Thulerpt_BR
dc.creatorPaul Grosspt_BR
dc.creatorAngélica Nogueira Rodriguespt_BR
dc.date.accessioned2023-05-05T21:10:13Z-
dc.date.available2023-05-05T21:10:13Z-
dc.date.issued2020-10-27-
dc.citation.volume6pt_BR
dc.citation.spage1617pt_BR
dc.citation.epage1630pt_BR
dc.identifier.doihttps://doi. org/10.1200/GO.20. 00099pt_BR
dc.identifier.issn2687-8941pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/52884-
dc.description.resumoPURPOSE: Little is known, or has been published previously, regarding consolidated data on the epidemiology of gynecologic cancers (GC) in Brazil. This article describes the incidence, morbidity, and mortality of women in Brazil affected with GC between the years of 2000 and 2017. METHODS: Incidence, morbidity, and mortality data from patients with a diagnosis of one out of the five most common GC, cervical (CC), uterine (UC), ovarian (OC), vulvar (VvC), and vaginal (VgC), were obtained from three governmental sources of data. RESULTS: From 2000 to 2015 CC, OC, and VgC incidence rates (IRs) decreased, whereas the IRs for UC and VvC remained relatively stable. Data from 382,932 women with GC were analyzed. Most patients presented with locally advanced or advanced disease at diagnosis: 60.1% of patients with CC, 31.2% of patients with UC, 67.2% of patients with OC, 45.2% of patients with VvC, and 67.0% of patients with VgC. Time from diagnosis to first treatment was ≥ 60 days in 58.0% of patients with CC, 58.5% of patients with UC, 27.0% of patients with OC, 55.3% of patients with VvC, and 52.7% of patients with VgC. Regarding mortality rates (MRs), with the exception of CC, UC, and VvC, which showed a slight decrease, MRs remained stable between 2000 and 2017. CONCLUSION: A comparison with international data indicates that Brazilian patients are diagnosed with more advanced disease and face a longer delay between diagnosis and first treatment. Despite advances in screening and treatment, GC mortality has not decreased satisfactorily in this country.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE GINECOLOGIA OBSTETRÍCIApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofJCO Global Oncology-
dc.rightsAcesso Abertopt_BR
dc.subjectGenital neoplasmspt_BR
dc.subjectFemalept_BR
dc.subjectBrazilpt_BR
dc.subjectIncidencept_BR
dc.subjectMorbiditypt_BR
dc.subjectMortalitypt_BR
dc.subject.otherNeoplasias dos genitais femininospt_BR
dc.subject.otherBrasilpt_BR
dc.subject.otherIncidênciapt_BR
dc.subject.otherMorbidadept_BR
dc.subject.otherMortalidadept_BR
dc.titlePanorama of gynecological cancer in Brazilpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://ascopubs.org/doi/full/10.1200/GO.20.00099?role=tabpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-8486-7861pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Panorama of gynecological cancer in brazil.pdf647.57 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.